{"DataElement":{"publicId":"2669281","version":"1","preferredName":"Cancer Identification Tumor Differentiation ICD-O-3 Grade Number Code","preferredDefinition":"The ICD-O-3 codes that represent the grade or degree of differentiation of the reportable tumor.","longName":"2669274v1.0:2644708v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2669274","version":"1","preferredName":"Cancer Identification Tumor Differentiation ICD-O-3_Code","preferredDefinition":"The grade or degree of differentiation of the reportable tumor.","longName":"2666870v1.0:2669271v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2666870","version":"1","preferredName":"Malignant Neoplasm Identified","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Identified; having the identity known or established.","longName":"C9305:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36033E9E-8A70-432F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-24","modifiedBy":"ONEDATA","dateModified":"2007-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2669271","version":"1","preferredName":"Neoplasm Differentiation ICD-O-3_Code","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.:Indicates the matching ICD-O-3 code for the NCI Thesaurus concept.","longName":"C3262:C18314:C66766","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ICD-O-3_Code","conceptCode":"C66766","definition":"Indicates the matching ICD-O-3 code for the NCI Thesaurus concept.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36806765-15E6-5B6A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-30","modifiedBy":"ONEDATA","dateModified":"2007-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"36806765-15F7-5B6A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2644708","version":"1","preferredName":"Tumor Differentiation  International Classification of Diseases for Oncology, Third Edition (ICD-O-3) Code","preferredDefinition":"An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004_In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably._The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._A system of numbered categories for representation of data","longName":"2644708v1.0","context":"PS-CC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"9","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"319EFC9A-2DB9-4274-E044-0003BA3F9857","beginDate":"2007-05-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-29","modifiedBy":"CURTIST","dateModified":"2007-05-29","deletedIndicator":"No"},{"value":"8","valueDescription":"Natural Killer Cell","ValueMeaning":{"publicId":"2644709","version":"1","preferredName":"Natural Killer Cell","longName":"2644709","preferredDefinition":"White blood cells that attack tumor cells and body cells that have been invaded by foreign substances.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Natural Killer Cell","conceptCode":"C12536","definition":"Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"319EFC9A-2DC7-4274-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"319EFC9A-2DDF-4274-E044-0003BA3F9857","beginDate":"2007-05-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-29","modifiedBy":"CURTIST","dateModified":"2007-05-29","deletedIndicator":"No"},{"value":"7","valueDescription":"Null cell","ValueMeaning":{"publicId":"2644710","version":"1","preferredName":"Null cell","longName":"2644710","preferredDefinition":"Null cell","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"319EFC9A-2DEB-4274-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"319EFC9A-2E05-4274-E044-0003BA3F9857","beginDate":"2007-05-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-29","modifiedBy":"CURTIST","dateModified":"2007-05-29","deletedIndicator":"No"},{"value":"6","valueDescription":"B cell","ValueMeaning":{"publicId":"2991892","version":"1","preferredName":"B cell","longName":"2991892","preferredDefinition":"Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC8B94A-9FCD-1457-E040-BB89AD430D33","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC8B94A-9FE6-1457-E040-BB89AD430D33","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"5","valueDescription":"T cell","ValueMeaning":{"publicId":"2991893","version":"1","preferredName":"T cell","longName":"2991893","preferredDefinition":"One type of white blood cell that attacks virus-infected cells, foreign cells, and cancer cells. T cells also produce a number of substances that regulate the immune response.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC8B94A-9FF0-1457-E040-BB89AD430D33","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC8B94A-A009-1457-E040-BB89AD430D33","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"4","valueDescription":"Grade IV","ValueMeaning":{"publicId":"2580054","version":"1","preferredName":"Grade IV","longName":"2580054","preferredDefinition":"Grade IV","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-05C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-23","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC8B94A-A01D-1457-E040-BB89AD430D33","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"3","valueDescription":"Grade III","ValueMeaning":{"publicId":"2568893","version":"1","preferredName":"Grade III","longName":"2568893","preferredDefinition":"Grade III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA2A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC8B94A-A032-1457-E040-BB89AD430D33","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"2","valueDescription":"Grade II","ValueMeaning":{"publicId":"2568892","version":"1","preferredName":"Grade II","longName":"2568892","preferredDefinition":"Grade II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA29-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC8B94A-A047-1457-E040-BB89AD430D33","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"},{"value":"1","valueDescription":"Grade I","ValueMeaning":{"publicId":"2568891","version":"1","preferredName":"Grade I","longName":"2568891","preferredDefinition":"Grade I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA28-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7DC8B94A-A052-1457-E040-BB89AD430D33","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"ONEDATA","dateModified":"2010-01-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435030","version":"1","preferredName":"NCI Administrative Concept","preferredDefinition":"Conceptual entities required by NCI operations and systems. Includes administrative, financial, organizational and quasi-scientific concepts required for NCI operations and systems. ","longName":"C28389","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432182-1611-25E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3009692","version":"1","preferredName":"International Classification of Diseases for Oncology, Third Edition Code","preferredDefinition":"The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms.:A system of numbered categories for representation of data.","longName":"C87061:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Classification of Diseases for Oncology, Third Edition","conceptCode":"C87061","definition":"The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6BD280-2FC2-0397-E040-BB89AD4336D5","latestVersionIndicator":"Yes","beginDate":"2010-02-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-02-12","modifiedBy":"ONEDATA","dateModified":"2010-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"319EFC8F-5BB3-3E3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-29","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3103505","version":"1","longName":"NAACCR 11.1","context":"PS-CC"},{"publicId":"3103520","version":"1","longName":"CancerID11.1","context":"PS-CC"},{"publicId":"3103506","version":"1","longName":"NAACCR 11.2","context":"PS-CC"},{"publicId":"3103521","version":"1","longName":"CancerID11.2","context":"PS-CC"},{"publicId":"3103507","version":"1","longName":"NAACCR 11.3","context":"PS-CC"},{"publicId":"3103537","version":"1","longName":"CancerID11.3","context":"PS-CC"},{"publicId":"3242108","version":"1","longName":"TextTreatment11.1","context":"PS-CC"},{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"3134731","version":"1","longName":"CancerID12.1","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"5899834","version":"1","longName":"CancerID16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464307","version":"1","longName":"CancerID18","context":"PS-CC"}]},{"publicId":"3021954","version":"1","longName":"Caris Life Sciences","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3060676","version":"1","longName":"Caris Registry","context":"NCIP"}]},{"publicId":"3595692","version":"1","longName":"Miraca Life Sciences","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3595693","version":"1","longName":"Miraca Registry","context":"NCIP"}]}],"AlternateNames":[{"name":"440","type":"NAACCR Item #","context":"PS-CC"},{"name":"GRADE","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Grade, Differentiation, or Cell Indicator (SEER) ","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"Grade/Differentiation (COC)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"Grade  Differentiation  or Cell Lineage Indicator (SEER/CCCR)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"Grade","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Grade/Differentiation (CoC)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Cancer Identification Tumor G","type":"Preferred Question Text","description":"Cancer Identification Tumor Grade Number Code","url":null,"context":"PS-CC"},{"name":"NAACCR, V 11.1 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)","url":"http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf","context":"PS-CC"},{"name":"Grade Description","type":"COMMENT","description":"For lymphomas and leukemias, field also is used to indicate T-, B-, Null-, or NK-cell origin. Code 8 was adopted for use with lymphoma cases diagnosed in 1995 and later.","url":null,"context":"PS-CC"},{"name":"SEER Manual","type":"REFERENCE","description":"SEER Manual","url":"http://seer.cancer.gov/tools/ssm/index.html","context":"PS-CC"},{"name":"FORDS Manual, Revised 2009","type":"REFERENCE","description":"See FORDS Manual for specifications of codes and data entry rules.","url":"http://www.facs.org/cancer/coc/fords/2009/fords2009.pdf","context":"PS-CC"},{"name":"Initial Tumor Grade","type":"Alternate Question Text","description":"Initial Tumor Grade","url":null,"context":"NCIP"},{"name":"Initial Grade/Differentiation","type":"Alternate Question Text","description":"Initial Grade/Differentiation","url":null,"context":"NCIP"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR V11.2 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d","context":"PS-CC"},{"name":"NAACCR V11.3 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d","context":"PS-CC"},{"name":"Differentiation/Cell Origin","type":"Alternate Question Text","description":"Differentiation/Cell Origin","url":null,"context":"NCIP"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Grade at initial diagnosis","url":null,"context":"Alliance"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"367F8083-6DCF-5D82-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-30","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}